Nutanix (NTNX) 10-Q 10 Jun 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Apr. 30, 2024	May 31, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-37883
Entity Registrant Name	NUTANIX, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0989767
Entity Address, Address Line One	1740 Technology Drive, Suite 150
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95110
City Area Code	(408)
Local Phone Number	216-8360
Title of 12(b) Security	Class A Common Stock, $0.000025 par value per share
Trading Symbol	NTNX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		246,640,821
Entity Central Index Key	0001618732
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 598,027	$ 512,929
Short-term investments	1,053,354	924,466
Accounts receivable, net of allowances of $733 and $1,619, respectively	225,301	157,251
Deferred commissions—current	148,435	120,001
Prepaid expenses and other current assets	114,123	147,087
Total current assets	2,139,240	1,861,734
Property and equipment, net	114,785	111,865
Operating lease right-of-use assets	96,895	93,554
Deferred commissions—non-current	204,357	237,990
Intangible assets, net	6,019	4,893
Goodwill	185,235	184,938
Other assets—non-current	28,393	31,941
Total assets	2,774,924	2,526,915
Current liabilities:
Accounts payable	40,286	29,928
Accrued compensation and benefits	173,339	143,679
Accrued expenses and other current liabilities	22,486	109,269
Deferred revenue—current	923,559	823,665
Operating lease liabilities—current	23,884	29,567
Total current liabilities	1,183,554	1,136,108
Deferred revenue—non-current	823,891	771,367
Operating lease liabilities—non-current	79,028	68,940
Convertible senior notes, net	1,271,966	1,218,165
Other liabilities—non-current	35,945	39,754
Total liabilities	3,394,384	3,234,334
Commitments and contingencies (Note 7)
Stockholders’ deficit:
Preferred stock, par value of $0.000025 per share- 200,000 shares authorized as of July 31, 2023 and April 30, 2024, no shares issued and outstanding as of July 31, 2023 and April 30, 2024	0	0
Common stock, par value of $0.000025 per share-1,000,000 Class A shares authorized as of July 31, 2023 and April 30, 2024; 239,607 and 246,932 Class A shares issued and outstanding as of July 31, 2023 and April 30, 2024, respectively	6	6
Additional paid-in capital	4,086,671	3,930,668
Accumulated other comprehensive (loss) income	(3,703)	(5,171)
Accumulated deficit	(4,702,434)	(4,632,922)
Total stockholders’ deficit	(619,460)	(707,419)
Total liabilities and stockholders’ deficit	$ 2,774,924	$ 2,526,915

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Accounts receivable, allowance for credit loss	$ 1,619	$ 733
Preferred stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	200,000	200,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common Class A [Member]
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)	1,000,000	1,000,000
Common stock, shares issued (in shares)	246,932	239,607
Common stock, shares outstanding (in shares)	246,932	239,607

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Revenue:
Total revenue	$ 524,577	$ 448,581	$ 1,600,864	$ 1,368,685
Cost of revenue:
Total cost of revenue	79,619	82,429	243,134	251,729
Gross profit	444,958	366,152	1,357,730	1,116,956
Operating expenses:
Sales and marketing	245,901	229,261	717,926	695,271
Research and development	159,220	143,016	471,596	434,760
General and administrative	51,425	52,515	148,457	182,728
Total operating expenses	456,546	424,792	1,337,979	1,312,759
(Loss) income from operations	(11,588)	(58,640)	19,751	(195,803)
Other (expense) income, net	659	(7,168)	(2,520)	(30,696)
(Loss) income before provision for income taxes	(10,929)	(65,808)	17,231	(226,499)
Provision for income taxes	4,687	5,161	15,905	14,774
Net (loss) income	$ (15,616)	$ (70,969)	$ 1,326	$ (241,273)
Net (loss) income per share attributable to Class A common stockholders, basic	$ (0.06)	$ (0.3)	$ 0.01	$ (1.04)
Net (loss) income per share attributable to Class A common stockholders, diluted	$ (0.06)	$ (0.3)	$ 0.05	$ (1.04)
Weighted average shares used in computing net (loss) income per share attributable to Class A common stockholders, basic	245,766	234,735	243,688	231,702
Weighted average shares used in computing net (loss) income per share attributable to Class A common stockholders, diluted	245,766	234,735	297,055	231,702
Product
Revenue:
Total revenue	$ 255,465	$ 212,507	$ 802,047	$ 671,619
Cost of revenue:
Total cost of revenue	8,469	12,430	28,105	40,452
Support, entitlements and other services
Revenue:
Total revenue	269,112	236,074	798,817	697,066
Cost of revenue:
Total cost of revenue	$ 71,150	$ 69,999	$ 215,029	$ 211,277

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ (15,616)	$ (70,969)	$ 1,326	$ (241,273)
Other comprehensive income (loss), net of tax:
Change in unrealized loss on available-for-salesecurities, net of tax	(4,582)	1,518	1,468	1,793
Comprehensive (loss) income	$ (20,198)	$ (69,451)	$ 2,794	$ (239,480)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Stockholders' equity, beginning balance at Jul. 31, 2022	$ (800,504)	$ 6	$ 3,583,928	$ (6,076)	$ (4,378,362)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2022		226,938
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	1,975		1,975
Issuance of common stock through employee equity incentive plans (in shares)		2,172
Issuance of common stock from ESPP purchase	18,947		18,947
Issuance of common stock from ESPP purchase (in shares)		998
Stock-based compensation	80,955		80,955
Other comprehensive income (loss)	(3,642)			(3,642)
Net Income (Loss)	(99,514)				(99,514)
Stockholders' equity, ending balance at Oct. 31, 2022	(801,783)	$ 6	3,685,805	(9,718)	(4,477,876)
Stockholders' equity, ending balance (in shares) at Oct. 31, 2022		230,108
Stockholders' equity, beginning balance at Jul. 31, 2022	(800,504)	$ 6	3,583,928	(6,076)	(4,378,362)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2022		226,938
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(241,273)
Stockholders' equity, ending balance at Apr. 30, 2023	(789,067)	$ 6	3,834,845	(4,283)	(4,619,635)
Stockholders' equity, ending balance (in shares) at Apr. 30, 2023		235,744
Stockholders' equity, beginning balance at Oct. 31, 2022	(801,783)	$ 6	3,685,805	(9,718)	(4,477,876)
Stockholders' equity, beginning balance (in shares) at Oct. 31, 2022		230,108
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	684		684
Issuance of common stock through employee equity incentive plans (in shares)		3,483
Stock-based compensation	85,290		85,290
Other comprehensive income (loss)	3,917			3,917
Net Income (Loss)	(70,790)				(70,790)
Stockholders' equity, ending balance at Jan. 31, 2023	(782,682)	$ 6	3,771,779	(5,801)	(4,548,666)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2023		233,591
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	372		372
Shares withheld related to net share settlement of equity award		(413)
Shares withheld related to net share value settlement of equity awards	(10,214)		(10,214)
Issuance of common stock through employee equity incentive plans (in shares)		2,566
Stock-based compensation	72,908		72,908
Other comprehensive income (loss)	1,518			1,518
Net Income (Loss)	(70,969)				(70,969)
Stockholders' equity, ending balance at Apr. 30, 2023	(789,067)	$ 6	3,834,845	(4,283)	(4,619,635)
Stockholders' equity, ending balance (in shares) at Apr. 30, 2023		235,744
Stockholders' equity, beginning balance at Jul. 31, 2023	(707,419)	$ 6	3,930,668	(5,171)	(4,632,922)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2023		239,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	547		547
Issuance of common stock through employee equity incentive plans (in shares)		3,274
Issuance of common stock from ESPP purchase	13,233		13,233
Issuance of common stock from ESPP purchase (in shares)		653
Repurchase and retirement of common stock	(17,513)		(7,774)		(9,739)
Repurchase and retirement of common stock (in shares)		(482)
Stock-based compensation	83,998		83,998
Other comprehensive income (loss)	796			796
Net Income (Loss)	(15,853)				(15,853)
Stockholders' equity, ending balance at Oct. 31, 2023	(642,211)	$ 6	4,020,672	(4,375)	(4,658,514)
Stockholders' equity, ending balance (in shares) at Oct. 31, 2023		243,052
Stockholders' equity, beginning balance at Jul. 31, 2023	(707,419)	$ 6	3,930,668	(5,171)	(4,632,922)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2023		239,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	1,326
Stockholders' equity, ending balance at Apr. 30, 2024	(619,460)	$ 6	4,086,671	(3,703)	(4,702,434)
Stockholders' equity, ending balance (in shares) at Apr. 30, 2024		246,932
Stockholders' equity, beginning balance at Oct. 31, 2023	(642,211)	$ 6	4,020,672	(4,375)	(4,658,514)
Stockholders' equity, beginning balance (in shares) at Oct. 31, 2023		243,052
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	1,370		1,370
Shares withheld related to net share settlement of equity award		(1,148)
Shares withheld related to net share value settlement of equity awards	(53,180)		(53,180)
Issuance of common stock through employee equity incentive plans (in shares)		3,689
Repurchase and retirement of common stock	(41,679)		(15,052)		(26,627)
Repurchase and retirement of common stock (in shares)		(934)
Stock-based compensation	85,969		85,969
Other comprehensive income (loss)	5,254			5,254
Net Income (Loss)	32,795				32,795
Stockholders' equity, ending balance at Jan. 31, 2024	(611,682)	$ 6	4,039,779	879	(4,652,346)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2024		244,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	1,413		1,413
Shares withheld related to net share settlement of equity award		(926)
Shares withheld related to net share value settlement of equity awards	(58,440)		(58,440)
Issuance of common stock through employee equity incentive plans (in shares)		2,756
Issuance of common stock from ESPP purchase	34,094		34,094
Issuance of common stock from ESPP purchase (in shares)		1,217
Repurchase and retirement of common stock	(46,939)		(12,467)		(34,472)
Repurchase and retirement of common stock (in shares)		(774)
Stock-based compensation	82,292		82,292
Other comprehensive income (loss)	(4,582)			(4,582)
Net Income (Loss)	(15,616)				(15,616)
Stockholders' equity, ending balance at Apr. 30, 2024	$ (619,460)	$ 6	$ 4,086,671	$ (3,703)	$ (4,702,434)
Stockholders' equity, ending balance (in shares) at Apr. 30, 2024		246,932

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		9 Months Ended
		Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities:
Net Income (Loss)		$ 1,326	$ (241,273)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		54,986	59,078
Stock-based compensation		252,259	239,153
Amortization of debt discount and issuance costs		33,738	31,767
Operating lease cost, net of accretion		24,009	27,065
Early exit of lease-related assets		0	(1,109)
Non-cash interest expense		15,143	14,772
Other		(14,117)	(6,275)
Changes in operating assets and liabilities:
Accounts receivable, net		(49,669)	(4,768)
Deferred commissions		5,199	16,919
Prepaid expenses and other assets		37,588	(33,858)
Accounts payable		10,326	(5,106)
Accrued compensation and benefits		29,660	2,356
Accrued expenses and other liabilities		(83,857)	53,451
Operating leases, net		(22,394)	(30,134)
Deferred revenue		134,037	92,056
Net cash provided by operating activities		428,234	214,094
Cash flows from investing activities:
Maturities of investments		625,519	722,983
Purchases of investments		(740,034)	(711,253)
Payments for acquisitions, net of cash acquired		(4,500)	0
Purchases of property and equipment		(54,813)	(52,603)
Net cash used in investing activities		(173,828)	(40,873)
Cash flows from financing activities:
Repayment of convertible notes		0	(145,704)
Proceeds from sales of shares through employee equity incentive plans		50,660	23,268
Taxes paid related to net share settlement of equity awards		(111,620)	(10,214)
Repurchases of common stock		(106,131)	0
Payment of finance lease obligations		(2,928)	(3,711)
Net cash used in financing activities		(170,019)	(136,361)
Net increase in cash, cash equivalents and restricted cash		84,387	36,860
Cash, cash equivalents and restricted cash—beginning of period		515,771	405,862
Cash, cash equivalents and restricted cash—end of period		600,158	442,722
Restricted cash	[1]	2,131	2,804
Cash and cash equivalents—end of period		598,027	439,918
Supplemental disclosures of cash flow information:
Cash paid for income taxes		20,938	21,578
Supplemental disclosures of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable and accrued and other liabilities		$ 983	$ 16,214
[1] Included within other assets—non-current in the condensed consolidated balance sheets.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Apr. 30, 2024	Jan. 31, 2024	Oct. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Apr. 30, 2024	Apr. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (15,616)	$ 32,795	$ (15,853)	$ (70,969)	$ (70,790)	$ (99,514)	$ 1,326	$ (241,273)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Apr. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Overview and Basis of Presentation	NOTE 1. OVERVIEW AND B ASIS OF PRESENTATION Organization and Description of Business Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our" or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa. We provide a leading enterprise cloud platform, which we call Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply run and move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure services, modern applications, analytics applications, and artificial intelligence ("AI") workloads, including machine learning and generative AI workloads, between on-premises and public clouds. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners") and delivered directly to our end customers. Principles of Consolidation and Significant Accounting Policies The accompanying condensed consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") and are consistent in all material respects with those included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the Securities and Exchange Commission ("SEC") on September 21, 2023. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited, but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. The consolidated balance sheet as of July 31, 2023 is derived from audited financial statements; however, it does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 . Use of Estimates The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the 2.50 % convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Risk Concentration of revenue and accounts receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the three and nine months ended April 30, 2023 and 2024 , no end customer accounted for more than 10 % of total revenue or accounts receivable. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Nine Months Ended July 31, April 30, Partners 2023 2024 2023 2024 Partner A 32 % 33 % 32 % 32 % 17 % 24 % Partner B 18 % 16 % 16 % 16 % 19 % 13 % Partner C (1) (1) 10 % 11 % (1) (1) Partner D (1) (1) (1) (1) 11 % (1) (1) Less than 10% Summary of Significant Accounting Policies There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 , filed with the SEC on September 21, 2023, that have had a material impact on our condensed consolidated financial statements. Recently Issued and Not Yet Adopted Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (the "FASB") issued accounting standards update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides for improvements to income tax disclosures. The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact this new standard will have on our disclosures. Correction to Prior Period Financial Statements In connection with the completed Audit Committee investigation, as initially disclosed in our Annual Report on Form 10-K/A filed with the SEC on May 24, 2023, and subsequent to the issuance of the condensed consolidated financial statements for the fiscal quarter ended October 31, 2022, we discovered an error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, resulting in an immaterial understatement of operating expenses and accrued expenses and other current liabilities for these prior periods. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements. We have prospectively corrected our previously issued financial statements to reflect the correction of this error rather than record a cumulative out-of-period adjustment. The correction reflects our estimates of future payments for past non-compliant use of third-party software. Actual amounts may vary from these estimates.

Revenue, Deferred Revenue and D

Revenue, Deferred Revenue and Deferred Commissions	9 Months Ended
	Apr. 30, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Revenue, Deferred Revenue and Deferred Commissions	NOTE 2. REVENUE, DEFERRED REV ENUE AND DEFERRED COMMISSIONS Disaggregation of Revenue and Revenue Recognition Nutanix Cloud Platform can be deployed on-premises in data centers or at the edge, running on a variety of qualified hardware platforms, in popular public cloud environments such as AWS and Microsoft Azure through Nutanix Cloud Clusters, or, in the case of our cloud-based software and software-as-a-service ("SaaS") offerings, via hosted service. Our subscription term-based licenses are sold separately, or can also be sold alongside configured-to-order servers. Our subscription term-based licenses typically have durations ranging from one to five years . Our cloud-based SaaS subscriptions generally have durations extending up to five years. The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Subscription $ 417,516 $ 486,620 $ 1,271,388 $ 1,498,081 Professional services 22,101 26,240 67,821 74,083 Other non-subscription product (1) 8,964 11,717 29,476 28,700 Total revenue $ 448,581 $ 524,577 $ 1,368,685 $ 1,600,864 (1) Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation. Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based SaaS offerings. • Ratable — We recognize revenue from software entitlement and support subscriptions and SaaS offerings ratably over the contractual service period, the substantial majority of which relate to software entitlement and support subscriptions. These offerings represented approximately $ 226.1 million and $ 663.8 million of our subscription revenue for the three and nine months ended April 30, 2023, respectively, and $ 254.8 million and $ 760.8 million of our subscription revenue for the three and nine months ended April 30, 2024, respectively. • Upfront — Revenue from our subscription software licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. These subscription software licenses represented approximately $ 191.4 million and $ 607.6 million of our subscription revenue for the three and nine months ended April 30, 2023, respectively, and $ 231.8 million and $ 737.3 million of our subscription revenue for the three and nine months ended April 30, 2024, respectively. Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed. Other non-subscription product revenue — Other non-subscription product revenue includes $ 8.4 million and $ 27.0 million of non-portable software revenue for the three and nine months ended April 30, 2023, respectively, $ 11.1 million and $ 26.3 million of non-portable software revenue for the three and nine months ended April 30, 2024, respectively, $ 0.6 million and $ 2.5 million of hardware revenue for the three and nine months ended April 30, 2023, respectively, and $ 0.6 million and $ 2.4 million of hardware revenue for the three and nine months ended April 30, 2024, respectively. • Non-portable software revenue — Non-portable software revenue includes sales of our enterprise cloud platform when delivered on a configured-to-order server by us or one of our OEM partners. The software licenses associated with these sales are typically non-portable and can be used over the life of the server on which the software is delivered. Revenue from our non-portable software products is generally recognized upon transfer of control to the customer. • Hardware revenue — In transactions where the hardware platform is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis. We consider the amount allocated to hardware revenue to be equivalent to the cost of the hardware procured. Hardware revenue is generally recognized upon transfer of control to the customer. Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price ("SSP") basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations. Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. The balance of unbilled accounts receivable, included in accounts receivable, net on the condensed consolidated balance sheets, was $ 16.3 million and $ 34.7 million as of July 31, 2023 and April 30, 2024, respectively. Payment terms on invoiced amounts are typically 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectability of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2023 and April 30, 2024 is presented in the accompanying condensed consolidated balance sheets. Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in the condensed consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in the condensed consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle and other factors. Deferred costs are periodically reviewed for impairment. Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our condensed consolidated statements of operations. Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertains to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the condensed consolidated balance sheet date. Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2023 $ 1,595,032 $ 357,991 Additions (1) 561,254 42,350 Revenue/commissions recognized ( 511,054 ) ( 47,448 ) Balance as of October 31, 2023 1,645,232 352,893 Additions (1) 628,495 54,872 Revenue/commissions recognized ( 565,233 ) ( 54,604 ) Balance as of January 31, 2024 1,708,494 353,161 Additions 563,533 54,505 Revenue/commissions recognized ( 524,577 ) ( 54,874 ) Balance as of April 30, 2024 $ 1,747,450 $ 352,792 (1) Includes both billed and unbilled amounts. During the three and nine months ended April 30, 2023 , we recognized revenue of approximately $ 218.7 million and $ 556.9 million pertaining to amounts deferred as of January 31, 2023 and July 31, 2022, respectively. During the three and nine months ended April 30, 2024 , we recognized revenue of approximately $ 254.2 million and $ 621.5 million pertaining to amounts deferred as of January 31, 2024 and July 31, 2023, respectively. Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $ 2.0 billion as of April 30, 2024 , of which we expect to recognize approximately 53 % over the next 12 months, and the remainder thereafter.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 3. FAIR VAL UE MEASUREMENTS The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 211,319 $ — $ — $ 211,319 U.S. Government securities — 6,999 — 6,999 Commercial paper — 34,830 — 34,830 Short-term investments: Corporate bonds — 452,703 — 452,703 Commercial paper — 215,219 — 215,219 U.S. Government securities — 256,544 — 256,544 Total measured at fair value $ 211,319 $ 966,295 $ — $ 1,177,614 Cash 259,781 Total cash, cash equivalents and short-term investments $ 1,437,395 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,700 $ 5,700 As of April 30, 2024 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 309,826 $ — $ — $ 309,826 U.S. Government securities — 11,442 — 11,442 Commercial paper — 38,321 — 38,321 Short-term investments: Corporate bonds — 641,171 — 641,171 Commercial paper — 130,057 — 130,057 U.S. Government securities — 282,126 — 282,126 Total measured at fair value $ 309,826 $ 1,103,117 $ — $ 1,412,943 Cash 238,438 Total cash, cash equivalents and short-term investments $ 1,651,381 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,030 $ 5,030 Financial Instruments Not Recorded at Fair Value on a Recurring Basis We report our financial instruments at fair value, with the exception of the 2026 Notes and the 0.25 % convertible senior notes due 2027 (the "2027 Notes", and together with the 2026 Notes, the "Notes"). Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2023 As of April 30, 2024 Carrying Estimated Carrying Estimated (in thousands) 2026 Notes $ 649,630 $ 1,043,889 $ 702,279 $ 1,881,373 2027 Notes 568,535 497,410 569,687 699,994 Total $ 1,218,165 $ 1,541,299 $ 1,271,966 $ 2,581,367 The carrying value of the 2026 Notes as of July 31, 2023 and April 30, 2024 included $ 47.6 million and $ 67.6 million, respectively, of non-cash interest expense that was added to the principal balance, net of unamortized debt discounts of $ 132.8 million and $ 103.5 million, respectively, and unamortized debt issuance costs of $ 15.2 million and $ 11.8 million, respectively. The carrying value of the 2027 Notes as of July 31, 2023 and April 30, 2024 was net of unamortized debt issuance costs of $ 6.5 million and $ 5.3 million, respectively. The total estimated fair value of the 2026 Notes is based on a binomial model. We consider the fair value of the 2026 Notes to be a Level III valuation, as the 2026 Notes are not publicly traded. The Level III inputs used to determine the estimated fair value of the 2026 Notes include the conversion rate, risk-free interest rate, discount rate, volatility, and the price of our Class A common stock. The total estimated fair value of the 2027 Notes was determined based on the closing trading price per $ 100 of the 2027 Notes as of the last day of trading for the period. We consider the fair value of the 2027 Notes to be a Level II valuation due to the limited trading activity.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	NOTE 4. BALANCE SHEET COMPONENTS Short-Term Investments The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2023 and April 30, 2024, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, as of July 31, 2023 and April 30, 2024, we did not record any credit losses for these investments. The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 617,690 Due in one to three years 435,664 Total $ 1,053,354 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consists of the following: As of July 31, April 30, (in thousands) Prepaid operating expenses $ 84,998 $ 71,106 VAT receivables 5,954 7,160 Other current assets 56,135 35,857 Total prepaid expenses and other current assets $ 147,087 $ 114,123 The decrease in prepaid expenses and other current assets from July 31, 2023 to April 30, 2024 was due primarily to the release of the insurance receivable and the settlement payment related to the February 2023 settlement of two securities class actions, as the settlement was paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 7. Property and Equipment, Net Property and equipment, net consists of the following: As of Estimated July 31, April 30, (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 390,378 $ 425,498 Demonstration units 12 60,985 59,439 Leasehold improvements (1) 64,667 67,727 Furniture and fixtures 60 16,132 16,202 Total property and equipment, gross 532,162 568,866 Less: accumulated depreciation ( 420,297 ) ( 454,081 ) Total property and equipment, net $ 111,865 $ 114,785 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. Depreciation expense related to our property and equipment was $ 16.0 million and $ 47.8 million for the three and nine months ended April 30, 2023 , respectively, and $ 16.7 million and $ 49.2 million for the three and nine months ended April 30, 2024, respectively. Goodwill and Intangible Assets, Net The $ 0.3 million increase in the carrying value of goodwill during the nine months ended April 30, 2024 was related to an immaterial acquisition completed during the second quarter of fiscal 2024. Intangible assets, net consists of the following: As of July 31, April 30, (in thousands) Developed technology $ 78,267 $ 79,838 Customer relationships 8,860 11,230 Trade name 4,170 4,200 Total intangible assets, gross 91,297 95,268 Less: Accumulated amortization of developed technology ( 73,411 ) ( 76,038 ) Accumulated amortization of customer relationships ( 8,823 ) ( 9,022 ) Accumulated amortization of trade name ( 4,170 ) ( 4,189 ) Total accumulated amortization ( 86,404 ) ( 89,249 ) Total intangible assets, net $ 4,893 $ 6,019 Amortization expense related to our intangible assets is recognized in the condensed consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name. The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2024 (remaining three months) $ 865 2025 2,540 2026 777 2027 777 2028 353 Thereafter 707 Total $ 6,019 Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, April 30, (in thousands) Accrued commissions $ 36,882 $ 43,029 Accrued vacation 24,840 27,479 Payroll taxes payable 17,427 24,719 Accrued wages and taxes 11,485 24,134 Accrued benefits 12,391 17,067 Accrued bonus 16,404 13,549 Contributions to ESPP withheld 10,145 9,505 Retirement 401(k) payable 1,915 590 Other 12,190 13,267 Total accrued compensation and benefits $ 143,679 $ 173,339 Accrued expenses and other current liabilities consists of the following: As of July 31, April 30, (in thousands) Accrued professional services $ 1,978 $ 2,193 Software usage liability 11,248 1,347 Litigation settlement reserves 71,000 — Income taxes payable 2,185 — Other 22,858 18,946 Total accrued expenses and other current liabilities $ 109,269 $ 22,486 The decrease in accrued expenses and other current liabilities from July 31, 2023 to April 30, 2024 was due primarily to the release of the litigation settlement reserve related to the settlement of two securities class actions, which was agreed to in February 2023 but paid out during the fiscal quarter ended October 31, 2023. For additional details on legal proceedings, refer to Note 7.

Convertible Senior Notes

Convertible Senior Notes	9 Months Ended
	Apr. 30, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	NOTE 5. CONVERTI BLE SENIOR NOTES 2023 Notes In January 2018, we issued the 2023 Notes with a 0 % interest rate for an aggregate principal amount of $ 575.0 million, due in 2023, in a private placement to qualified institutional buyers pursuant to Rule144A under the Securities Act. On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $ 416.5 million in aggregate principal amount of 2023 Notes for $ 477.3 million in aggregate principal amount of 2027 Notes. We also entered into privately negotiated transactions with certain holders of the 2023 Notes pursuant to which we repurchased approximately $ 12.8 million in aggregate principal amount of 2023 Notes for cash. Following the closing of these exchanges and repurchases, approximately $ 145.7 million in aggregate principal amount of 2023 Notes remained outstanding with terms unchanged. In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $ 145.7 million. The following table sets forth the total interest expense recognized related to the 2023 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Interest expense related to amortization of debt issuance $ — $ — $ 248 $ — Note Hedges and Warrants Concurrently with the offering of the 2023 Notes in January 2018, we entered into convertible note hedge transactions with certain bank counterparties, whereby we have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a conversion price of approximately $ 48.85 per share, subject to adjustment for certain specified events. The total cost of the convertible note hedge transactions was approximately $ 143.2 million. In addition, we sold warrants to certain bank counterparties, whereby the holders of the warrants have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a price of $ 73.46 per share, subject to adjustment for certain specified events. We received approximately $ 88.0 million in cash proceeds from the sale of these warrants. In September 2021, in connection with the exchange and repurchase transactions described above, we terminated portions of the convertible note hedge transactions and warrant transactions previously entered into with certain financial institutions in connection with the issuance of the 2023 Notes. The net effect of these unwind transactions was a $ 21.5 million cash payment received, consisting of an $ 18.4 million payment for the warrant unwind and the receipt of $ 39.9 million from the hedge unwind. The amounts paid and received as part of the unwind transactions were recorded to additional paid-in capital within the condensed consolidated balance sheet. In January 2023, the convertible note hedges and warrant transactions expired concurrently with the maturity of the 2023 Notes. No settlement is required as the stock has remained below the strike price throughout the unwind settlement averaging period. 2026 Notes In September 2020, we issued $ 750.0 million in aggregate principal amount of the 2026 Notes to BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital, LP ("Bain"). The total net proceeds from this offering were approximately $ 723.7 million, after deducting $ 26.3 million of debt issuance costs. The 2026 Notes bear interest at a rate of 2.50 % per annum, with such interest to be paid in kind ("PIK") on the 2026 Notes held by Bain through an increase in the principal amount of the 2026 Notes, and paid in cash on any 2026 Notes transferred to entities that are not affiliated with Bain. Interest on the 2026 Notes has accrued from the date of issuance, September 24, 2020, and is added to the principal amount, in the case of the 2026 Notes held by Bain, or paid in cash, in the case of the 2026 Notes held by entities that are not affiliated with Bain, as applicable, on a semi-annual basis (on March 15 and September 15 of each year). The 2026 Notes mature on September 15, 2026, subject to earlier conversion, redemption or repurchase. The 2026 Notes are convertible at an initial conversion rate of 36.036 shares of Class A common stock per $ 1,000 principal amount of the 2026 Notes, which is equal to an initial conversion price of $ 27.75 per share, subject to customary anti-dilution and other adjustments, including in connection with any make-whole adjustments as a result of certain extraordinary transactions. In September 2021, the one-year anniversary of the issuance of the 2026 Notes, the conversion price was subject to a one-time adjustment, based on the level of achievement of certain financial milestones and as a result, the conversion price became fixed at $ 27.75 per share. For each $ 1,000 principal amount of 2026 Notes a holder elects to convert, we have initially elected to pay cash with respect to the first $ 1,000 of conversion value and deliver shares of Class A common stock with respect to any conversion value in excess of $ 1,000 . Pursuant to the indenture governing the 2026 Notes, we may elect to change such default settlement method with respect to any conversion of 2026 Notes held by Bain by delivering written notice to Bain at least five trading days prior to the effective time of such settlement election. Additionally, if Bain elects to convert any 2026 Notes it holds upon our delivery of a notice of redemption, Bain will have the right to elect whether such conversion is settled in cash, shares of our Class A common stock or a combination thereof. On or after September 15, 2025, the 2026 Notes will be redeemable by us, at our option, in the event that the closing sale price of our Class A common stock has been at least 150 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any consecutive 30 trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide the redemption notice, for cash, at a redemption price of 100 % of the principal amount of such 2026 Notes, plus any accrued and unpaid interest to, but excluding, the redemption date. Holders who convert their 2026 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2026 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2026 Notes) prior to the maturity date, holders of the 2026 Notes may require us to repurchase for cash all or a portion of their 2026 Notes at a repurchase price equal to 100 % of the principal amount of the repurchased 2026 Notes, plus accrued and unpaid interest thereon. In accordance with accounting guidance on embedded conversion features, we valued and bifurcated the conversion option associated with the 2026 Notes from the respective host debt instrument, which is treated as a debt discount, and initially recorded the conversion option of $ 230.9 million as a derivative liability in our condensed consolidated balance sheet, with the corresponding amount recorded as a discount to the 2026 Notes to be amortized over the term of the 2026 Notes using the effective interest method. The 2026 Notes consisted of the following: As of July 31, April 30, (in thousands) Principal amounts: Principal $ 750,000 $ 750,000 Non-cash interest expense converted to principal 47,569 67,633 Unamortized debt discount (conversion feature) (1) ( 132,769 ) ( 103,526 ) Unamortized debt issuance costs (1) ( 15,170 ) ( 11,828 ) Net carrying amount $ 649,630 $ 702,279 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. As of April 30, 2024, the remaining life of the 2026 Notes was approximately 2.4 years . The following table sets forth the total interest expense recognized related to the 2026 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Interest expense related to amortization of debt discount $ 9,246 $ 9,920 $ 27,258 $ 29,244 Interest expense related to amortization of debt issuance 1,056 1,133 3,114 3,341 Non-cash interest expense 4,955 5,079 14,772 15,143 Total interest expense $ 15,257 $ 16,132 $ 45,144 $ 47,728 Non-cash interest expense is related to the 2.5 % PIK interest that we accrued from the issuance of the 2026 Notes through April 30, 2024 and was recognized within other expense, net in the condensed consolidated statement of operations and other liabilities–non-current in the condensed consolidated balance sheet. The accrued PIK interest will be converted to the principal balance of the 2026 Notes at each payment date and will be convertible to shares of our Class A common stock at maturity or when converted. Upon the conversion price of the 2026 Notes becoming fixed, subject to customary anti-dilution and other adjustments, in September 2021, the embedded conversion option for the 2026 Notes no longer required bifurcation because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. The carrying amount of the derivative liability of $ 698.2 million as of that date was reclassified to additional paid-in capital within the condensed consolidated balance sheet. The remaining debt discount that arose from the original bifurcation continues to be amortized over the term of the 2026 Notes. 2027 Notes In September 2021, we issued $ 575 million in aggregate principal amount of 0.25 % convertible senior notes due 2027 consisting of (i) approximately $ 477.3 million principal amount of 2027 Notes in exchange for approximately $ 416.5 million principal amount of the 2023 Notes (the "Exchange Transactions") and (ii) approximately $ 97.7 million principal amount of 2027 Notes for cash (the "Subscription Transactions"). We did not receive any cash proceeds from the Exchange Transactions. The net cash proceeds from the Subscription Transactions were approximately $ 88.4 million after deducting the offering expenses for both the Exchange Transactions and the Subscription Transactions. We used (i) approximately $ 14.7 million of the net cash proceeds from the Subscription Transactions to repurchase approximately $ 12.8 million principal amount of the 2023 Notes and (ii) approximately $ 58.5 million of the net cash proceeds from the Subscription Transactions to repurchase approximately 1.4 million shares of our Class A common stock. The 2027 Notes bear interest at a rate of 0.25 % per annum, and pay interest semi-annually in arrears on each April 1 and October 1. The 2027 Notes will mature on October 1, 2027, unless earlier converted, redeemed or repurchased. The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $ 1,000 of principal of the 2027 Notes is initially convertible into 17.3192 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $ 57.74 per share, subject to customary anti-dilution adjustments. Holders of these 2027 Notes may convert their 2027 Notes at their option at any time prior to the close of the business day immediately preceding July 1, 2027, only under the following circumstances: (1) during any fiscal quarter, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding fiscal quarter is greater than or equal to 130 % of the then applicable conversion price for the Notes per share of common stock; (2) during the five business day period after any consecutive five trading day period in which, for each trading day of that period, the trading price per $ 1,000 principal amount of 2027 Notes for such trading day was less than 98 % of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day; (3) if we call the 2027 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of certain specified corporate events. Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. We intend to settle the principal of the 2027 Notes in cash. The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. Holders who convert their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2027 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2027 Notes) prior to the maturity date, holders of the 2027 Notes may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to 100 % of the principal amount of the repurchased 2027 Notes, plus accrued and unpaid interest thereon. In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $ 64.9 million difference between the total reacquisition price paid and the net carrying amount of the 2023 Notes was recognized as a debt extinguishment loss within other expense, net in the condensed consolidated statement of operations. The 2027 Notes consisted of the following: As of July 31, April 30, (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 6,465 ) ( 5,313 ) Net carrying amount $ 568,535 $ 569,687 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %. As of April 30, 2024, the remaining life of the 2027 Notes was approximately 3.4 years . The following table sets forth the total interest expense recognized related to the 2027 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Contractual interest expense $ 548 $ 359 $ 1,266 $ 993 Interest expense related to amortization of debt issuance 383 385 1,147 1,153 Total interest expense $ 931 $ 744 $ 2,413 $ 2,146

Leases

Leases	9 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Leases	NOTE 6. LEASES We have operating leases for offices, research and development facilities and datacenters and finance leases for certain datacenter equipment. Our leases have remaining lease terms of one year to approximately six years , some of which include options to renew or terminate. We do not include renewal options in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Our lease agreements do not contain any residual value guarantees or restrictive covenants. Total operating lease cost was $ 10.6 million and $ 32.6 million for the three and nine months ended April 30, 2023 , respectively, and $ 9.8 million and $ 29.3 million for the three and nine months ended April 30, 2024 , respectively, excluding short-term lease costs, variable lease costs and sublease income, each of which were not material. Variable lease costs primarily include common area maintenance charges. Total finance lease cost was $ 1.0 million and $ 2.8 million for the three and nine months ended April 30, 2023 , respectively, and $ 1.3 million and $ 3.6 million for the three and nine months ended April 30, 2024, respectively. During the nine months ended April 30, 2023, we signed agreements to early exit certain office spaces in the United States and the Netherlands. The reductions in the lease terms resulted in decreases to the carrying amounts of the operating lease liabilities and the operating lease right-of-use assets on our condensed consolidated balance sheet as of April 30, 2023. In addition, we recorded $ 1.7 million of expense in our condensed consolidated statements of operations for the nine months ended April 30, 2023. Supplemental balance sheet information related to our leases is as follows: As of July 31, April 30, (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 181,226 $ 187,075 Accumulated amortization ( 87,672 ) ( 90,180 ) Operating lease right-of-use assets, net $ 93,554 $ 96,895 Operating lease liabilities—current $ 29,567 $ 23,884 Operating lease liabilities—non-current 68,940 79,028 Total operating lease liabilities $ 98,507 $ 102,912 Weighted average remaining lease term (in years): 5.0 4.9 Weighted average discount rate: 6.1 % 6.4 % As of July 31, April 30, (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 18,279 $ 19,345 Accumulated amortization (1) ( 5,558 ) ( 8,445 ) Finance lease right-of-use assets , net (1) $ 12,721 $ 10,900 Finance lease liabilities—current (2) $ 3,518 $ 3,888 Finance lease liabilities—non-current (3) 9,722 7,680 Total finance lease liabilities $ 13,240 $ 11,568 Weighted average remaining lease term (in years): 3.7 3.1 Weighted average discount rate: 6.8 % 7.0 % (1) Included in the condensed consolidated balance sheets within property and equipment, net. (2) Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in the condensed consolidated balance sheets within other liabilities—non-current. Supplemental cash flow and other information related to our leases is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 11,798 $ 8,156 $ 35,561 $ 28,194 Operating cash flows from finance leases $ — $ 247 $ — $ 689 Financing cash flows from finance leases $ 1,367 $ 923 $ 3,711 $ 2,652 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ — $ 6,657 $ 5,971 $ 26,462 Finance leases $ 5,468 $ 381 $ 7,011 $ 1,066 The undiscounted cash flows for our lease liabilities as of April 30, 2024 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2024 (remaining three months) $ 6,321 $ 1,144 $ 7,465 2025 29,526 4,576 34,102 2026 20,880 3,874 24,754 2027 18,819 2,164 20,983 2028 18,649 1,153 19,802 Thereafter 26,812 40 26,852 Total lease payments 121,007 12,951 133,958 Less: imputed interest ( 18,095 ) ( 1,383 ) ( 19,478 ) Total lease obligation 102,912 11,568 114,480 Less: current lease obligations ( 23,884 ) ( 3,888 ) ( 27,772 ) Long-term lease obligations $ 79,028 $ 7,680 $ 86,708 As of April 30, 2024 , we did not have any additional operating lease commitments for office leases that have not yet commenced.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 7. COMMITMENTS AND CONTINGENCIES Purchase Commitments In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of April 30, 2024, we had up to approximately $ 109.0 million of non-cancelable purchase obligations and other commitments pertaining to our daily business operations, and up to approximately $ 76.7 million in the form of guarantees to certain of our contract manufacturers. Legal Proceedings In February 2023, we settled the two previously disclosed securities class actions that were brought on behalf of persons or entities who purchased or otherwise acquired our securities and/or transacted in publicly traded call options and/or put options on our stock between November 30, 2017 and May 30, 2019. The total settlement amount was $ 71.0 million, which was accrued as of July 31, 2023 and included within accrued expenses and other current liabilities on our condensed consolidated balance sheet. In June 2023, $ 31.1 million of the settlement funds were deposited in escrow and were included within prepaid expenses and other current assets on our condensed consolidated balance sheet as of July 31, 2023. In October 2023, the court granted final approval of the settlement and the funds were subsequently released from escrow and paid out to the plaintiffs. The settlement accrual was partially offset by a receivable of $ 39.9 million for amounts recoverable under our applicable insurance policies, which was included within prepaid expenses and other current assets on our condensed consolidated balance sheet as of July 31, 2023. During the fiscal year ended July 31, 2023, we recorded charges of $ 38.7 million for the settlement and applicable legal fees, net of our insurance receivable. In September 2023, we settled the previously disclosed securities class action that was brought on behalf of a putative class consisting of persons or entities who purchased or otherwise acquired our securities between September 21, 2021 and March 6, 2023. The settlement payment was not material. In November 2023, the court dismissed the securities class action pursuant to the settlement agreement with prejudice as to the lead plaintiff and without prejudice as to the other members of the putative class. In addition, in December 2023, the plaintiff in the related previously disclosed stockholder derivative action voluntarily dismissed the action. We are not currently a party to any legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Stockholders' Equity	NOTE 8. STOCKHO LDERS’ EQUITY We have one class of outstanding common stock consisting of Class A common stock. As of April 30, 2024 , we had 1.0 billion shares of Class A common stock authorized, with a par value of $ 0.000025 per share. As of April 30, 2024 , we had 246.9 million shares of Class A common stock issued and outstanding. Holders of Class A common stock are entitled to one vote for each share of Class A common stock held on all matters submitted to a vote of stockholders. Share Repurchases In August 2023, our Board of Directors authorized the repurchase of up to $ 350.0 million of our Class A common stock. Repurchases may be made from time to time through open market purchases or through privately negotiated transactions subject to market conditions, applicable legal requirements and other relevant factors. The repurchase program does not obligate us to acquire any particular amount of our common stock, and may be suspended at any time at our discretion. During the three and nine months ended April 30, 2024 , we repurchased 0.8 million and 2.2 million shares, respectively, of Class A common stock in open market transactions at a weighted average price of $ 60.64 and $ 48.46 per share, respectively, for an aggregate purchase price of $ 46.9 million and $ 106.1 million, respectively. As of April 30, 2024 , $ 243.9 million remained available for future share repurchases.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	NOTE 9. EQUITY INCENTIVE PLANS Stock Plans We have one active equity incentive plan, the 2016 Equity Incentive Plan (the "2016 Plan"), and two inactive equity incentive plans, the 2010 Stock Plan ("2010 Plan") and the 2011 Stock Plan ("2011 Plan"). Our stockholders approved the 2016 Plan in March 2016 and it became effective in connection with our initial public offering ("IPO"). As a result, at the time of the IPO, we ceased granting additional stock awards under the 2010 Plan and 2011 Plan and both plans were terminated. Any outstanding stock awards under the 2010 Plan and 2011 Plan remain outstanding, subject to the terms of the applicable plan and award agreements, until such shares are issued under those stock awards, by exercise of stock options or settlement of restricted stock units ("RSUs"), or until those stock awards become vested or expired by their terms. Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, restricted stock units ("RSUs"), and stock appreciation rights to employees, directors and consultants. We initially reserved 22.4 million shares of our Class A common stock for issuance under the 2016 Plan. The number of shares of Class A common stock available for issuance under the 2016 Plan also includes an annual increase on the first day of each fiscal year, beginning in fiscal 2018, equal to the lesser of: 18.0 million shares, 5 % of the outstanding shares of all classes of common stock as of the last day of our immediately preceding fiscal year, or such other amount as may be determined by the Board. Accordingly, on August 1, 2022 and 2023, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 11.3 million and 12.0 million shares, respectively, pursuant to these provisions. As of April 30, 2024 , we had reserved a total of 44.2 million shares for the issuance of equity awards under the Stock Plans, of which 18.3 million shares were still available for grant. Restricted Stock Units RSUs settle into shares of Class A common stock upon vesting. During the second quarter of fiscal 2024, we began funding withholding taxes due on the vesting of employee RSUs by net share settlement, rather than our previous approach of selling shares of Class A common stock to cover taxes upon vesting of such awards. The payment of the withheld taxes to the tax authorities is reflected as a financing activity within the condensed consolidated statements of cash flows. Performance RSUs We have historically granted RSUs that have both service and performance conditions to our executives and employees ("Performance RSUs"). Vesting of Performance RSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of Performance RSUs are subject to the performance conditions actually being met. In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.3 million RSUs subject to certain performance conditions ("PRSUs") to our President and CEO. These PRSUs have a grant date fair value per unit of $ 45.86 and will vest up to 200 % based on achievement of specified annual recurring revenue and free cash flow hurdles over a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date. Market Stock Units In connection with his hiring, in December 2020, the Compensation Committee of our Board of Directors approved the grant of 0.7 million RSUs subject to certain market conditions ("MSUs") to our President and CEO. These MSUs have a weighted average grant date fair value per unit of $ 35.69 and will vest up to 133 % based upon the achievement of certain stock price targets over a performance period of approximately 4.0 years, subject to his continuous service on each vesting date. In October 2021, August 2022, and August 2023, the Compensation Committee of our Board of Directors approved the grant of approximately 0.4 million, 1.3 million, and 0.8 million MSUs, respectively, to certain of our executives. These MSUs have a weighted average grant date fair value per unit of approximately $ 46.20 , $ 27.89 , and $ 47.09 , respectively, and will vest up to 200 % of the target number of MSUs based upon our total shareholder return relative to the total shareholder return of companies in the Nasdaq Composite Index over a performance period of approximately 2.8 years, 2.9 years, and 2.9 years, respectively, subject to continuous service on each vesting date. Additional MSUs have been granted with similar terms, but were not material. In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.2 million MSUs to our President and CEO. These MSUs have a weighted average grant date fair value of $ 62.85 and will vest up to 200 % based on achievement of specified stock price hurdles at any time during a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date. We used Monte Carlo simulations to calculate the fair value of these awards on the grant date, or modification date, as applicable. A Monte Carlo simulation requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We recognize stock-based compensation expense related to these MSUs using the graded vesting attribution method over the respective service periods. As of April 30, 2024 , approximately 2.6 million MSUs remained outstanding. Below is a summary of RSU activity, including PRSUs and MSUs, under the Stock Plans: Number of Weighted Average (in thousands) Outstanding at July 31, 2023 24,774 $ 24.46 Granted 10,923 $ 35.44 Released ( 9,076 ) $ 25.54 Forfeited ( 1,092 ) $ 25.74 Outstanding at April 30, 2024 25,529 $ 28.72 Stock Options We did no t grant any stock options during the nine months ended April 30, 2024 . A total of 0.6 million stock options were exercised during the nine months ended April 30, 2024 , with a weighted average exercise price per share of $ 5.18 . As of April 30, 2024 , 0.4 million stock options, with a weighted average exercise price of $ 9.47 per share, a weighted average remaining contractual life of 0.7 years and an aggregate intrinsic value of $ 20.7 million, remained outstanding. Employee Stock Purchase Plan In December 2015, the Board adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. Our stockholders subsequently approved amendments to the Original 2016 ESPP in December 2019 and December 2022 (as amended, the "2016 ESPP"). Under the 2016 ESPP, the maximum number of shares of Class A common stock available for sale is 13.8 million shares. The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to 15 % of eligible compensation, subject to caps of $ 25,000 in any calendar year and 1,000 shares on any purchase date. The 2016 ESPP provides for 12-month offering periods, generally beginning in March and September of each year, and each offering period consists of two six-month purchase periods. On each purchase date, participating employees will purchase Class A common stock at a price per share equal to 85 % of the lesser of the fair market value of our Class A common stock on (i) the first trading day of the applicable offering period or (ii) the last trading day of each purchase period in the applicable offering period. If the stock price of our Class A common stock on any purchase date in an offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period. During the nine months ended April 30, 2024 , 1.9 million shares of common stock were purchased under the 2016 ESPP for an aggregate amount of $ 47.3 million. As of April 30, 2024 , 10.7 million shares were available for future issuance under the 2016 ESPP. We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Nine Months Ended April 30, 2023 2024 Expected term (in years) 0.74 0.78 Risk-free interest rate 4.2 % 5.1 % Volatility 60.5 % 47.2 % Dividend yield — % — % Stock-Based Compensation Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Cost of revenue: Product $ 1,831 $ 1,576 $ 6,103 $ 5,201 Support, entitlements and other services 6,565 6,391 20,083 20,690 Sales and marketing 19,383 18,901 63,425 61,110 Research and development 32,003 38,719 107,116 117,664 General and administrative 13,126 16,705 42,426 47,594 Total stock-based compensation expense $ 72,908 $ 82,292 $ 239,153 $ 252,259 As of April 30, 2024 , unrecognized stock-based compensation expense related to outstanding stock awards was approximately $ 649.3 million and is expected to be recognized over a weighted average period of approximately 2.4 years.

Income Taxes

Income Taxes	9 Months Ended
	Apr. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 10. IN COME TAXES The income tax provisions of $ 5.2 million and $ 14.8 million for the three and nine months ended April 30, 2023 , respectively, and $ 4.7 million and $ 15.9 million for the three and nine months ended April 30, 2024 , respectively, primarily consisted of foreign taxes on our international operations and U.S. state income taxes. We continue to maintain a full valuation allowance for our U.S. Federal and state deferred tax assets and a partial valuation allowance related to certain foreign net operating losses.

Restructuring Charges

Restructuring Charges	9 Months Ended
	Apr. 30, 2024
Restructuring Charges [Abstract]
Restructuring Charges	NOTE 11. RESTRUCTURING CHARGES In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represented approximately 4 % of our total employees , following a review of our business structure and after taking other cost-cutting measures to reduce expenses. This headcount reduction was part of our efforts to drive toward profitable growth. As of April 30, 2024 , we recognized total restructuring charges of approximately $ 16.3 million, which consisted primarily of one-time severance and other termination benefit costs directly related to this reduction in force. Of the approximately $ 16.3 million recognized, $ 0.4 million is included within support, entitlements and other services cost of revenue, $ 13.4 million is included within sales and marketing expense, $ 2.3 million is included within research and development expense, and $ 0.2 million is included within general and administrative expense on our condensed consolidated statements of operations. During the nine months ended April 30, 2023 , we recognized restructuring charges of $ 5.3 million and made cash payments of $ 15.8 million. During the nine months ended April 30, 2024, we did no t incur any charges and made cash payments of $ 0.4 million. As of April 30, 2024, our remaining restructuring liability, included within accrued compensation and benefits in our condensed consolidated balance sheet, was not material. We do not expect to record any material future charges related to this reduction in force.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	NOTE 12. NET INCOME (L OSS) PER SHARE Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include shares issuable upon the exercise of stock options, the vesting of RSUs, and each purchase under the 2016 ESPP, and common stock issuable upon the conversion of convertible debt under the if-converted method. In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded. The computation of basic and diluted net income (loss) per share attributable to common stockholders is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands, except per share data) Numerator: Net (loss) income $ ( 70,969 ) $ ( 15,616 ) $ ( 241,273 ) $ 1,326 Add: Interest expense related to convertible senior — — — 12,749 Diluted net (loss) income $ ( 70,969 ) $ ( 15,616 ) $ ( 241,273 ) $ 14,075 Denominator: Weighted average shares, basic 234,735 245,766 231,702 243,688 Add: Dilutive effect of common stock equivalents — — — 53,367 Weighted average shares, diluted 234,735 245,766 231,702 297,055 Net (loss) income per share attributable to common $ ( 0.30 ) $ ( 0.06 ) $ ( 1.04 ) $ 0.01 Net (loss) income per share attributable to common $ ( 0.30 ) $ ( 0.06 ) $ ( 1.04 ) $ 0.05 The following weighted-average shares of common stock were excluded from the computation of diluted net (loss) income per share for the periods presented, as their effect would have been antidilutive: Nine Months Ended April 30, 2023 2024 (in thousands) Outstanding stock options and RSUs 28,116 473 Employee stock purchase plan 2,032 — Common stock issuable upon the conversion of the Notes 36,986 — Total 67,134 473 Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Common stock issuable upon the conversion of convertible debt represents the antidilutive impact of the 2023 Notes, 2026 Notes and 2027 Notes under the if-converted method.

Segment Information

Segment Information	9 Months Ended
	Apr. 30, 2024
Segment Reporting [Abstract]
Segment Information	NOTE 13. SEGME NT INFORMATION Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment. The following table sets forth revenue by geographic location based on bill-to location: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) U.S. $ 233,835 $ 283,842 $ 764,972 $ 882,790 Europe, the Middle East and Africa 124,248 147,065 346,065 423,566 Asia Pacific 77,742 82,502 226,047 258,763 Other Americas 12,756 11,168 31,601 35,745 Total revenue $ 448,581 $ 524,577 $ 1,368,685 $ 1,600,864 The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, April 30, (in thousands) United States $ 78,404 $ 81,266 International 33,461 33,519 Total long-lived assets $ 111,865 $ 114,785

SUBSEQUENT EVENT

SUBSEQUENT EVENT	9 Months Ended
	Apr. 30, 2024
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 14. SUBSEQUENT EVENT Subsequent to April 30, 2024, on June 6, 2024, BCPE Nucleon (DE) SPV, LP delivered a notice of conversion to convert $ 817.6 million aggregate principal amount of the 2026 Notes, representing all of the outstanding principal amount of the 2026 Notes. Under the terms of the indenture governing the 2026 Notes, we are required to settle the conversion by paying $ 817.6 million in cash and delivering approximately 16.9 million shares of Class A common stock. We expect to use a portion of our existing cash, cash equivalents and short-term investments to settle the cash portion of the conversion, which is expected to occur during the fiscal quarter ending July 31, 2024. We expect to deliver the shares in late July 2024, following required regulatory approvals.

Overview and Basis of Present_2

Overview and Basis of Presentation (Policies)	9 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Organization and Description of Business	Organization and Description of Business Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our" or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa. We provide a leading enterprise cloud platform, which we call Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply run and move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure services, modern applications, analytics applications, and artificial intelligence ("AI") workloads, including machine learning and generative AI workloads, between on-premises and public clouds. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners") and delivered directly to our end customers.
Principles of Consolidation and Significant Accounting Policies	Principles of Consolidation and Significant Accounting Policies The accompanying condensed consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") and are consistent in all material respects with those included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023, filed with the Securities and Exchange Commission ("SEC") on September 21, 2023. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited, but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. The consolidated balance sheet as of July 31, 2023 is derived from audited financial statements; however, it does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 .
Use of Estimates	Use of Estimates The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the 2.50 % convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Risk	Concentration of Risk Concentration of revenue and accounts receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the three and nine months ended April 30, 2023 and 2024 , no end customer accounted for more than 10 % of total revenue or accounts receivable. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Nine Months Ended July 31, April 30, Partners 2023 2024 2023 2024 Partner A 32 % 33 % 32 % 32 % 17 % 24 % Partner B 18 % 16 % 16 % 16 % 19 % 13 % Partner C (1) (1) 10 % 11 % (1) (1) Partner D (1) (1) (1) (1) 11 % (1) (1) Less than 10%
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2023 , filed with the SEC on September 21, 2023, that have had a material impact on our condensed consolidated financial statements.
Recently Issued and Not Yet Adopted Accounting Pronouncements	Recently Issued and Not Yet Adopted Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (the "FASB") issued accounting standards update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides for improvements to income tax disclosures. The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact this new standard will have on our disclosures.
Correction to Prior Period Financial Statements	Correction to Prior Period Financial Statements In connection with the completed Audit Committee investigation, as initially disclosed in our Annual Report on Form 10-K/A filed with the SEC on May 24, 2023, and subsequent to the issuance of the condensed consolidated financial statements for the fiscal quarter ended October 31, 2022, we discovered an error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, resulting in an immaterial understatement of operating expenses and accrued expenses and other current liabilities for these prior periods. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements. We have prospectively corrected our previously issued financial statements to reflect the correction of this error rather than record a cumulative out-of-period adjustment. The correction reflects our estimates of future payments for past non-compliant use of third-party software. Actual amounts may vary from these estimates.

Overview and Basis of Present_3

Overview and Basis of Presentation (Tables)	9 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Schedules of Concentration of Revenue and Accounts Receivable	For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Nine Months Ended July 31, April 30, Partners 2023 2024 2023 2024 Partner A 32 % 33 % 32 % 32 % 17 % 24 % Partner B 18 % 16 % 16 % 16 % 19 % 13 % Partner C (1) (1) 10 % 11 % (1) (1) Partner D (1) (1) (1) (1) 11 % (1) (1) Less than 10%

Revenue, Deferred Revenue and_2

Revenue, Deferred Revenue and Deferred Commissions (Tables)	9 Months Ended
	Apr. 30, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Revenue by Arrangement, Disclosure	The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Subscription $ 417,516 $ 486,620 $ 1,271,388 $ 1,498,081 Professional services 22,101 26,240 67,821 74,083 Other non-subscription product (1) 8,964 11,717 29,476 28,700 Total revenue $ 448,581 $ 524,577 $ 1,368,685 $ 1,600,864 (1) Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation.
Deferred Revenue, by Arrangement, Disclosure	Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2023 $ 1,595,032 $ 357,991 Additions (1) 561,254 42,350 Revenue/commissions recognized ( 511,054 ) ( 47,448 ) Balance as of October 31, 2023 1,645,232 352,893 Additions (1) 628,495 54,872 Revenue/commissions recognized ( 565,233 ) ( 54,604 ) Balance as of January 31, 2024 1,708,494 353,161 Additions 563,533 54,505 Revenue/commissions recognized ( 524,577 ) ( 54,874 ) Balance as of April 30, 2024 $ 1,747,450 $ 352,792 (1) Includes both billed and unbilled amounts.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Apr. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured on Recurring Basis	The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 211,319 $ — $ — $ 211,319 U.S. Government securities — 6,999 — 6,999 Commercial paper — 34,830 — 34,830 Short-term investments: Corporate bonds — 452,703 — 452,703 Commercial paper — 215,219 — 215,219 U.S. Government securities — 256,544 — 256,544 Total measured at fair value $ 211,319 $ 966,295 $ — $ 1,177,614 Cash 259,781 Total cash, cash equivalents and short-term investments $ 1,437,395 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,700 $ 5,700 As of April 30, 2024 Level I Level II Level III Total (in thousands) Financial Assets, Current: Cash equivalents: Money market funds $ 309,826 $ — $ — $ 309,826 U.S. Government securities — 11,442 — 11,442 Commercial paper — 38,321 — 38,321 Short-term investments: Corporate bonds — 641,171 — 641,171 Commercial paper — 130,057 — 130,057 U.S. Government securities — 282,126 — 282,126 Total measured at fair value $ 309,826 $ 1,103,117 $ — $ 1,412,943 Cash 238,438 Total cash, cash equivalents and short-term investments $ 1,651,381 Financial Assets, Non-Current: Convertible note receivable $ — $ — $ 5,030 $ 5,030 The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2023 As of April 30, 2024 Carrying Estimated Carrying Estimated (in thousands) 2026 Notes $ 649,630 $ 1,043,889 $ 702,279 $ 1,881,373 2027 Notes 568,535 497,410 569,687 699,994 Total $ 1,218,165 $ 1,541,299 $ 1,271,966 $ 2,581,367

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date	The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 617,690 Due in one to three years 435,664 Total $ 1,053,354
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consists of the following: As of July 31, April 30, (in thousands) Prepaid operating expenses $ 84,998 $ 71,106 VAT receivables 5,954 7,160 Other current assets 56,135 35,857 Total prepaid expenses and other current assets $ 147,087 $ 114,123
Schedule of Property and Equipment, Net	Property and equipment, net consists of the following: As of Estimated July 31, April 30, (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 390,378 $ 425,498 Demonstration units 12 60,985 59,439 Leasehold improvements (1) 64,667 67,727 Furniture and fixtures 60 16,132 16,202 Total property and equipment, gross 532,162 568,866 Less: accumulated depreciation ( 420,297 ) ( 454,081 ) Total property and equipment, net $ 111,865 $ 114,785 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.
Schedule of Intangible Assets, Net	Intangible assets, net consists of the following: As of July 31, April 30, (in thousands) Developed technology $ 78,267 $ 79,838 Customer relationships 8,860 11,230 Trade name 4,170 4,200 Total intangible assets, gross 91,297 95,268 Less: Accumulated amortization of developed technology ( 73,411 ) ( 76,038 ) Accumulated amortization of customer relationships ( 8,823 ) ( 9,022 ) Accumulated amortization of trade name ( 4,170 ) ( 4,189 ) Total accumulated amortization ( 86,404 ) ( 89,249 ) Total intangible assets, net $ 4,893 $ 6,019
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2024 (remaining three months) $ 865 2025 2,540 2026 777 2027 777 2028 353 Thereafter 707 Total $ 6,019
Schedule of Accrued Liabilities	Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, April 30, (in thousands) Accrued commissions $ 36,882 $ 43,029 Accrued vacation 24,840 27,479 Payroll taxes payable 17,427 24,719 Accrued wages and taxes 11,485 24,134 Accrued benefits 12,391 17,067 Accrued bonus 16,404 13,549 Contributions to ESPP withheld 10,145 9,505 Retirement 401(k) payable 1,915 590 Other 12,190 13,267 Total accrued compensation and benefits $ 143,679 $ 173,339 Accrued expenses and other current liabilities consists of the following: As of July 31, April 30, (in thousands) Accrued professional services $ 1,978 $ 2,193 Software usage liability 11,248 1,347 Litigation settlement reserves 71,000 — Income taxes payable 2,185 — Other 22,858 18,946 Total accrued expenses and other current liabilities $ 109,269 $ 22,486

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	9 Months Ended
	Apr. 30, 2024
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2023 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Interest expense related to amortization of debt issuance $ — $ — $ 248 $ —
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2026 Notes consisted of the following: As of July 31, April 30, (in thousands) Principal amounts: Principal $ 750,000 $ 750,000 Non-cash interest expense converted to principal 47,569 67,633 Unamortized debt discount (conversion feature) (1) ( 132,769 ) ( 103,526 ) Unamortized debt issuance costs (1) ( 15,170 ) ( 11,828 ) Net carrying amount $ 649,630 $ 702,279 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2026 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Interest expense related to amortization of debt discount $ 9,246 $ 9,920 $ 27,258 $ 29,244 Interest expense related to amortization of debt issuance 1,056 1,133 3,114 3,341 Non-cash interest expense 4,955 5,079 14,772 15,143 Total interest expense $ 15,257 $ 16,132 $ 45,144 $ 47,728
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2027 Notes consisted of the following: As of July 31, April 30, (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 6,465 ) ( 5,313 ) Net carrying amount $ 568,535 $ 569,687 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2027 Notes: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Contractual interest expense $ 548 $ 359 $ 1,266 $ 993 Interest expense related to amortization of debt issuance 383 385 1,147 1,153 Total interest expense $ 931 $ 744 $ 2,413 $ 2,146

Leases (Tables)

Leases (Tables)	9 Months Ended
	Apr. 30, 2024
Leases [Abstract]
Assets and Liabilities, Lessee	Supplemental balance sheet information related to our leases is as follows: As of July 31, April 30, (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 181,226 $ 187,075 Accumulated amortization ( 87,672 ) ( 90,180 ) Operating lease right-of-use assets, net $ 93,554 $ 96,895 Operating lease liabilities—current $ 29,567 $ 23,884 Operating lease liabilities—non-current 68,940 79,028 Total operating lease liabilities $ 98,507 $ 102,912 Weighted average remaining lease term (in years): 5.0 4.9 Weighted average discount rate: 6.1 % 6.4 % As of July 31, April 30, (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 18,279 $ 19,345 Accumulated amortization (1) ( 5,558 ) ( 8,445 ) Finance lease right-of-use assets , net (1) $ 12,721 $ 10,900 Finance lease liabilities—current (2) $ 3,518 $ 3,888 Finance lease liabilities—non-current (3) 9,722 7,680 Total finance lease liabilities $ 13,240 $ 11,568 Weighted average remaining lease term (in years): 3.7 3.1 Weighted average discount rate: 6.8 % 7.0 % (1) Included in the condensed consolidated balance sheets within property and equipment, net. (2) Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in the condensed consolidated balance sheets within other liabilities—non-current.
Supplemental Cash Flow and Other Information Related to Leases	Supplemental cash flow and other information related to our leases is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 11,798 $ 8,156 $ 35,561 $ 28,194 Operating cash flows from finance leases $ — $ 247 $ — $ 689 Financing cash flows from finance leases $ 1,367 $ 923 $ 3,711 $ 2,652 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ — $ 6,657 $ 5,971 $ 26,462 Finance leases $ 5,468 $ 381 $ 7,011 $ 1,066
Lessee Operating and Finance Lease, Liability, Maturity	The undiscounted cash flows for our lease liabilities as of April 30, 2024 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2024 (remaining three months) $ 6,321 $ 1,144 $ 7,465 2025 29,526 4,576 34,102 2026 20,880 3,874 24,754 2027 18,819 2,164 20,983 2028 18,649 1,153 19,802 Thereafter 26,812 40 26,852 Total lease payments 121,007 12,951 133,958 Less: imputed interest ( 18,095 ) ( 1,383 ) ( 19,478 ) Total lease obligation 102,912 11,568 114,480 Less: current lease obligations ( 23,884 ) ( 3,888 ) ( 27,772 ) Long-term lease obligations $ 79,028 $ 7,680 $ 86,708

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Apr. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of RSUs Activity	Below is a summary of RSU activity, including PRSUs and MSUs, under the Stock Plans: Number of Weighted Average (in thousands) Outstanding at July 31, 2023 24,774 $ 24.46 Granted 10,923 $ 35.44 Released ( 9,076 ) $ 25.54 Forfeited ( 1,092 ) $ 25.74 Outstanding at April 30, 2024 25,529 $ 28.72
Schedule of ESPP Valuation Assumptions	We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Nine Months Ended April 30, 2023 2024 Expected term (in years) 0.74 0.78 Risk-free interest rate 4.2 % 5.1 % Volatility 60.5 % 47.2 % Dividend yield — % — %
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) Cost of revenue: Product $ 1,831 $ 1,576 $ 6,103 $ 5,201 Support, entitlements and other services 6,565 6,391 20,083 20,690 Sales and marketing 19,383 18,901 63,425 61,110 Research and development 32,003 38,719 107,116 117,664 General and administrative 13,126 16,705 42,426 47,594 Total stock-based compensation expense $ 72,908 $ 82,292 $ 239,153 $ 252,259

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Income (Loss) Per Share	The computation of basic and diluted net income (loss) per share attributable to common stockholders is as follows: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands, except per share data) Numerator: Net (loss) income $ ( 70,969 ) $ ( 15,616 ) $ ( 241,273 ) $ 1,326 Add: Interest expense related to convertible senior — — — 12,749 Diluted net (loss) income $ ( 70,969 ) $ ( 15,616 ) $ ( 241,273 ) $ 14,075 Denominator: Weighted average shares, basic 234,735 245,766 231,702 243,688 Add: Dilutive effect of common stock equivalents — — — 53,367 Weighted average shares, diluted 234,735 245,766 231,702 297,055 Net (loss) income per share attributable to common $ ( 0.30 ) $ ( 0.06 ) $ ( 1.04 ) $ 0.01 Net (loss) income per share attributable to common $ ( 0.30 ) $ ( 0.06 ) $ ( 1.04 ) $ 0.05
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following weighted-average shares of common stock were excluded from the computation of diluted net (loss) income per share for the periods presented, as their effect would have been antidilutive: Nine Months Ended April 30, 2023 2024 (in thousands) Outstanding stock options and RSUs 28,116 473 Employee stock purchase plan 2,032 — Common stock issuable upon the conversion of the Notes 36,986 — Total 67,134 473

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Apr. 30, 2024
Segment Reporting [Abstract]
Schedule of Revenue by Geographic Area	The following table sets forth revenue by geographic location based on bill-to location: Three Months Ended Nine Months Ended 2023 2024 2023 2024 (in thousands) U.S. $ 233,835 $ 283,842 $ 764,972 $ 882,790 Europe, the Middle East and Africa 124,248 147,065 346,065 423,566 Asia Pacific 77,742 82,502 226,047 258,763 Other Americas 12,756 11,168 31,601 35,745 Total revenue $ 448,581 $ 524,577 $ 1,368,685 $ 1,600,864
Schedule of Long-lived Assets by Geographical Location	The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, April 30, (in thousands) United States $ 78,404 $ 81,266 International 33,461 33,519 Total long-lived assets $ 111,865 $ 114,785

Overview and Basis of Present_4

Overview and Basis of Presentation - Schedules of Concentration of Revenue and Accounts Receivable (Details) - Partner Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023	Jul. 31, 2023
Partner A | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	33%	32%	32%	32%
Partner A | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage			24%		17%
Partner B | Revenue
Concentration Risk [Line Items]
Concentration risk percentage	16%	18%	16%	16%
Partner B | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage			13%		19%
Partner C | Revenue
Concentration Risk [Line Items]
Concentration risk percentage			11%	10%
Partner D | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage					11%

Overview and Basis of Present_5

Overview and Basis of Presentation - Additional Information (Details)	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023	Sep. 24, 2020
Partner [Member] | Customer Concentration Risk [Member] | Revenue
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Concentration risk percentage	10%	10%	10%	10%
2026 Convertible Senior Notes | Convertible Debt [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Interest rate, stated percentage	2.50%		2.50%		2.50%

Revenue, Deferred Revenue and_3

Revenue, Deferred Revenue and Deferred Commissions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023	Jul. 31, 2023
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 524,577	$ 448,581	$ 1,600,864	$ 1,368,685
Unbilled Contracts Receivable	34,700		34,700		$ 16,300
Amount deferred in prior period	254,200	218,700	621,500	556,900
Contracted revenue not recognized	$ 2,000,000		$ 2,000,000
Percent expected to be recognized in next year	53%		53%
Ratable
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 254,800	226,100	$ 760,800	663,800
Upfront
Deferred Revenue Arrangement [Line Items]
Total revenue	231,800	191,400	737,300	607,600
Non-portable software
Deferred Revenue Arrangement [Line Items]
Total revenue	11,100	8,400	26,300	27,000
Hardware
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 600	$ 600	$ 2,400	$ 2,500
Minimum
Deferred Revenue Arrangement [Line Items]
Software, license term			1 year
Maximum
Deferred Revenue Arrangement [Line Items]
Software, license term			5 years

Revenue, Deferred Revenue and_4

Revenue, Deferred Revenue and Deferred Commissions - Revenue by Arrangement, Disclosure (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Condensed Income Statements, Captions [Line Items]
Total revenue		$ 524,577	$ 448,581	$ 1,600,864	$ 1,368,685
Subscription
Condensed Income Statements, Captions [Line Items]
Total revenue		486,620	417,516	1,498,081	1,271,388
Professional services
Condensed Income Statements, Captions [Line Items]
Total revenue		26,240	22,101	74,083	67,821
Other non-subscription product
Condensed Income Statements, Captions [Line Items]
Total revenue	[1]	$ 11,717	$ 8,964	$ 28,700	$ 29,476
[1] Prior to fiscal 2024, these amounts were presented as separate line items, Non-portable software and Hardware, as described below. Prior period amounts have been updated to conform to the current period presentation.

Revenue, Deferred Revenue and_5

Revenue, Deferred Revenue and Deferred Commissions - Deferred Revenue, by Arrangement, Disclosure (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Jan. 31, 2024		Oct. 31, 2023
Movement in Deferred Commissions [Roll Forward]
Deferred commissions, beginning balance	$ 353,161	$ 352,893		$ 357,991
Additions	54,505	54,872	[1]	42,350	[1]
Revenue/commissions recognized	(54,874)	(54,604)		(47,448)
Deferred commissions, ending balance	352,792	353,161		352,893
Deferred revenue, beginning balance	1,708,494	1,645,232		1,595,032
Additions	563,533	628,495	[1]	561,254	[1]
Revenue/commissions recognized	(524,577)	(565,233)		(511,054)
Deferred revenue, ending balance	$ 1,747,450	$ 1,708,494		$ 1,645,232
[1] Includes both billed and unbilled amounts.

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Financial Assets:
Short-term investments:	$ 1,053,354	$ 924,466
Recurring
Financial Assets:
Total measured at fair value	1,412,943	1,177,614
Cash	238,438	259,781
Total cash, cash equivalents and short-term investments	1,651,381	1,437,395
Recurring | Corporate bonds
Financial Assets:
Short-term investments:	641,171	452,703
Recurring | Money market funds
Financial Assets:
Cash equivalents:	309,826	211,319
Recurring | Commercial paper
Financial Assets:
Cash equivalents:	38,321	34,830
Short-term investments:	130,057	215,219
Recurring | U.S. government securities
Financial Assets:
Cash equivalents:	11,442	6,999
Short-term investments:	282,126	256,544
Recurring | Convertible Note Receivable
Financial Assets:
Assets, Noncurrent, Total	5,030	5,700
Recurring | Level I
Financial Assets:
Total measured at fair value	309,826	211,319
Recurring | Level I | Corporate bonds
Financial Assets:
Short-term investments:	0	0
Recurring | Level I | Money market funds
Financial Assets:
Cash equivalents:	309,826	211,319
Recurring | Level I | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level I | U.S. government securities
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0
Recurring | Level I | Convertible Note Receivable
Financial Assets:
Assets, Noncurrent, Total	0	0
Recurring | Level II
Financial Assets:
Total measured at fair value	1,103,117	966,295
Recurring | Level II | Corporate bonds
Financial Assets:
Short-term investments:	641,171	452,703
Recurring | Level II | Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring | Level II | Commercial paper
Financial Assets:
Cash equivalents:	38,321	34,830
Short-term investments:	130,057	215,219
Recurring | Level II | U.S. government securities
Financial Assets:
Cash equivalents:	11,442	6,999
Short-term investments:	282,126	256,544
Recurring | Level II | Convertible Note Receivable
Financial Assets:
Assets, Noncurrent, Total	0	0
Recurring | Level III
Financial Assets:
Total measured at fair value	0	0
Recurring | Level III | Corporate bonds
Financial Assets:
Short-term investments:	0	0
Recurring | Level III | Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring | Level III | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level III | U.S. government securities
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level III | Convertible Note Receivable
Financial Assets:
Assets, Noncurrent, Total	$ 5,030	$ 5,700

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
		Apr. 30, 2024	Jul. 31, 2023	Sep. 30, 2021	Sep. 22, 2021	Sep. 24, 2020	Jan. 31, 2018
2023 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage							0%
Debt outstanding					$ 145,700
2026 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage		2.50%				2.50%
Non-cash interest expense converted to principal		$ 67,633	$ 47,569
Unamortized discount	[1]	103,526	132,769
Unamortized debt issuance cost	[1]	$ 11,828	15,170
2027 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage		0.25%
2027 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage		0.25%		0.25%
Unamortized debt issuance cost	[2]	$ 5,313	$ 6,465
Closing trading price		$ 100
[1] Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Fair Value Measurements - Non-r

Fair Value Measurements - Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - Convertible Debt - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 1,271,966	$ 1,218,165
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	2,581,367	1,541,299
2026 Convertible Senior Notes | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	702,279	649,630
2026 Convertible Senior Notes | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	1,881,373	1,043,889
2027 Convertible Senior Notes | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	569,687	568,535
2027 Convertible Senior Notes | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 699,994	$ 497,410

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Due within one year	$ 617,690
Due in one to three years	435,664
Total	$ 1,053,354	$ 924,466

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid operating expenses	$ 71,106	$ 84,998
VAT receivables	7,160	5,954
Other current assets	35,857	56,135
Total prepaid expenses and other current assets	$ 114,123	$ 147,087

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands		Apr. 30, 2024	Jul. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross		$ 568,866	$ 532,162
Less: accumulated depreciation		(454,081)	(420,297)
Total property and equipment, net		$ 114,785	111,865
Computer, production, engineering and other equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life		36 months
Total property and equipment, gross		$ 425,498	390,378
Demonstration units
Property, Plant and Equipment [Line Items]
Estimated Useful Life		12 months
Total property and equipment, gross		$ 59,439	60,985
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	[1]	$ 67,727	64,667
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Useful Life		60 months
Total property and equipment, gross		$ 16,202	$ 16,132
[1] Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Property, Plant and Equipment [Line Items]
Change In Carrying Value Of Goodwill			$ 0.3
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Depreciation	$ 16.7	$ 16	$ 49.2	$ 47.8

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, gross	$ 95,268	$ 91,297
Less:
Total accumulated amortization	(89,249)	(86,404)
Total intangible assets, net	6,019	4,893
Developed technology
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, gross	79,838	78,267
Less:
Total accumulated amortization	(76,038)	(73,411)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, gross	11,230	8,860
Less:
Total accumulated amortization	(9,022)	(8,823)
Trade Names
Finite-Lived Intangible Assets [Line Items]
Total intangible assets, gross	4,200	4,170
Less:
Total accumulated amortization	$ (4,189)	$ (4,170)

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Finite-lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining three months)	$ 865
2025	2,540
2026	777
2027	777
2028	353
Thereafter	707
Total	$ 6,019

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Accrued Compensation Benefits (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Employee-related Liabilities, Current [Abstract]
Accrued commissions	$ 43,029	$ 36,882
Accrued vacation	27,479	24,840
Payroll taxes payable	24,719	17,427
Accrued wages and taxes	24,134	11,485
Accrued benefits	17,067	12,391
Accrued bonus	13,549	16,404
Contributions to ESPP withheld	9,505	10,145
Retirement 401(k) payable	590	1,915
Other	13,267	12,190
Total accrued compensation and benefits	$ 173,339	$ 143,679

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Other Liabilities Disclosure [Abstract]
Accrued professional services	$ 2,193	$ 1,978
Software usage liability	1,347	11,248
Litigation settlement reserves	0	71,000
Income taxes payable	0	2,185
Other	18,946	22,858
Accrued expenses and other current liabilities	$ 22,486	$ 109,269

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Details) $ / shares in Units, shares in Millions			1 Months Ended			9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($) $ / shares	Sep. 24, 2020 USD ($) d $ / shares	Jan. 31, 2023 USD ($)	Sep. 30, 2021 USD ($) d $ / shares shares	Jan. 31, 2018 USD ($) $ / shares shares	Apr. 30, 2024 USD ($)	Jul. 31, 2023 USD ($)	Sep. 22, 2021 USD ($)
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Loss on debt extinguishment							$ 64,900,000
Number of securities called by warrants or rights (in shares) | shares					11.8
Payments for convertible note hedges					$ 143,200,000
Exercise price of warrants (in dollars per share) | $ / shares					$ 73.46
Proceeds from issuance of warrants					$ 88,000,000
2023 Convertible Senior Notes | Common Class A [Member]
Debt Instrument [Line Items]
Number of securities called by warrants or rights (in shares) | shares					11.8
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage						0.25%
Principal				$ 1,000
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage					0%
Face amount					$ 575,000,000
Debt outstanding								$ 145,700,000
Convertible debt				416,500,000
Repurchase amount				12,800,000
Proceeds from unwind transactions				21,500,000
Payments for unwinding of warrants				18,400,000
Proceeds from unwinding of convertible note hedges				39,900,000
Conversion price (in dollars per share) | $ / shares					$ 48.85
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage		2.50%				2.50%
Face amount	$ 750,000,000
Principal						$ 750,000,000	750,000,000
Conversion ratio		36.036
Conversion price (in dollars per share) | $ / shares	$ 27.75
Threshold trading days | d		20
Threshold consecutive trading days | d		30
Threshold percentage of stock price trigger		150%
Redemption price, percentage		100%
Debt instrument, term						2 years 4 months 24 days
Proceeds from the issuance of convertible notes, net of issuance costs	$ 723,700,000
Payments of debt issuance costs	26,300,000
Debt instrument, principal amount for conversion into common stock	1,000	$ 1,000
Derivative liability		$ 230,900,000		$ 698,200,000
Debt Instrument convertible conversion price 1	1,000
Convertible Debt | 2026 Convertible Senior Notes | Common Class A [Member]
Debt Instrument [Line Items]
Conversion price (in dollars per share) | $ / shares		$ 27.75
Debt Instrument convertible conversion excess value	$ 1,000
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage				0.25%		0.25%
Face amount				$ 575,000,000
Principal						$ 575,000,000	$ 575,000,000
Convertible debt				477,300,000
Debt instrument for cash, net				88,400,000
Notes for cash				97,700,000
Repurchase amount				$ 14,700,000
Conversion ratio				17.3192
Conversion price (in dollars per share) | $ / shares				$ 57.74
Threshold trading days | d				20
Threshold consecutive trading days | d				30
Redemption price, percentage				100%
Debt instrument, term						3 years 4 months 24 days
Debt instrument, principal amount for conversion into common stock				$ 1,000
Convertible Debt | 2027 Convertible Senior Notes | Minimum
Debt Instrument [Line Items]
Threshold percentage of stock price trigger				130%
Convertible Debt | 2027 Convertible Senior Notes | Common Class A [Member]
Debt Instrument [Line Items]
Repurchase amount				$ 58,500,000
Number of share repurchase | shares				1.4
Convertible Debt | 2027 Convertible Senior Notes | Common Class A [Member] | Maximum
Debt Instrument [Line Items]
Threshold percentage of stock price trigger				98%
Convertible Debt | Exchange Transactions | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Face amount								416,500,000
Convertible Debt | Exchange Transactions | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Face amount								477,300,000
Convertible Debt | Cash Transaction
Debt Instrument [Line Items]
Repayments of debt			$ 145,700,000
Convertible Debt | Cash Transaction | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Repurchase amount								$ 12,800,000

Convertible Senior Notes - Comp

Convertible Senior Notes - Components of Debt (Details) - USD ($)		Apr. 30, 2024	Jul. 31, 2023	Sep. 30, 2021
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal				$ 1,000
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Principal		$ 750,000,000	$ 750,000,000
Non-cash interest expense converted to principal		67,633,000	47,569,000
Unamortized debt discount (conversion feature)	[1]	(103,526,000)	(132,769,000)
Unamortized debt issuance costs	[1]	(11,828,000)	(15,170,000)
Net carrying amount		702,279,000	649,630,000
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal		575,000,000	575,000,000
Unamortized debt issuance costs	[2]	(5,313,000)	(6,465,000)
Net carrying amount		$ 569,687,000	$ 568,535,000
[1] Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Convertible Senior Notes - Co_2

Convertible Senior Notes - Components of Notes (Parenthetical) (Details) - Convertible Debt	Apr. 30, 2024
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	7.05%
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.52%

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Debt Instrument [Line Items]
Non-cash interest expense			$ 15,143	$ 14,772
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt issuance costs	$ 0	$ 0	0	248
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt discount	9,920	9,246	29,244	27,258
Interest expense related to amortization of debt issuance costs	1,133	1,056	3,341	3,114
Non-cash interest expense	5,079	4,955	15,143	14,772
Total interest expense	16,132	15,257	47,728	45,144
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Contractual interest expense	359	548	993	1,266
Interest expense related to amortization of debt issuance costs	385	383	1,153	1,147
Total interest expense	$ 744	$ 931	$ 2,146	$ 2,413

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Lessee, Lease, Description [Line Items]
Operating lease, cost	$ 9.8	$ 10.6	$ 29.3	$ 32.6
Finance lease, cost	$ 1.3	$ 1	3.6	$ 2.8
Operating lease early exit expenses			$ 1.7
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term			1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term			6 years

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet (Details) - USD ($) $ in Thousands		Apr. 30, 2024	Jul. 31, 2023
Operating leases
Operating lease right-of-use assets, gross		$ 187,075	$ 181,226
Accumulated amortization		(90,180)	(87,672)
Operating lease right-of-use assets, net		96,895	93,554
Operating lease liabilities—current		23,884	29,567
Operating lease liabilities—non-current		79,028	68,940
Total lease obligation		$ 102,912	$ 98,507
Weighted average remaining lease term (in years)		4 years 10 months 24 days	5 years
Weighted average discount rate		6.40%	6.10%
Finance leases
Finance lease right-of-use assets, gross	[1]	$ 19,345	$ 18,279
Accumulated amortization	[1]	(8,445)	(5,558)
Finance lease right-of-use assets, net	[1]	10,900	12,721
Finance lease liabilities-current	[2]	3,888	3,518
Finance lease liabilities-non-current	[3]	7,680	9,722
Total lease obligation		$ 11,568	$ 13,240
Weighted average remaining lease term (in years)		3 years 1 month 6 days	3 years 8 months 12 days
Weighted average discount rate		7%	6.80%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]		Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accrued Liabilities, Current	Accrued Liabilities, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]		Liabilities	Liabilities
[1] Included in the condensed consolidated balance sheets within property and equipment, net. Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. Included in the condensed consolidated balance sheets within other liabilities—non-current.

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow and Other Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Operating cash flows from operating leases	$ 8,156	$ 11,798	$ 28,194	$ 35,561
Operating cash flows from finance leases	247	0	689	0
Financing cash flows from finance leases	923	1,367	2,652	3,711
Lease liabilities arising from obtaining right-of-use assets from operating leases	6,657	0	26,462	5,971
Lease liabilities arising from obtaining right-of-use assets from finance leases	$ 381	$ 5,468	$ 1,066	$ 7,011

Leases - Remaining Maturity Und

Leases - Remaining Maturity Under Topic 842 (Details) - USD ($) $ in Thousands		Apr. 30, 2024	Jul. 31, 2023
Operating Leases
2024 (remaining three months)		$ 6,321
2025		29,526
2026		20,880
2027		18,819
2028		18,649
Thereafter		26,812
Total lease payments		121,007
Less: imputed interest		(18,095)
Total lease obligation		102,912	$ 98,507
Less: current lease obligations		(23,884)	(29,567)
Long-term lease obligations		79,028	68,940
Finance leases
2024 (remaining three months)		1,144
2025		4,576
2026		3,874
2027		2,164
2028		1,153
Thereafter		40
Total lease payments		12,951
Less: imputed interest		(1,383)
Total lease obligation		11,568	13,240
Less: current lease obligations	[1]	(3,888)	(3,518)
Long-term lease obligations	[2]	7,680	$ 9,722
Total
2024 (remaining three months)		7,465
2025		34,102
2026		24,754
2027		20,983
2028		19,802
Thereafter		26,852
Total lease payments		133,958
Less: imputed interest		(19,478)
Total lease obligation		114,480
Less: current lease obligations		(27,772)
Long-term lease obligations		$ 86,708
[1] Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. Included in the condensed consolidated balance sheets within other liabilities—non-current.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2023	Apr. 30, 2024	Jun. 30, 2023	Feb. 28, 2023
Loss Contingencies [Line Items]
Legal Fees	$ 38.7
Settlement funds deposited in escrow			$ 31.1
Litigation Settlement Reserves				$ 71
Amounts recoverable under insurance policies	$ 39.9
Non-contract Vendors
Loss Contingencies [Line Items]
Purchase obligation		$ 109
Contract Manufacturer
Loss Contingencies [Line Items]
Purchase obligation		$ 76.7

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
	Apr. 30, 2024 USD ($) Class Vote $ / shares shares	Apr. 30, 2024 USD ($) Class Vote $ / shares shares	Apr. 30, 2023 USD ($)	Aug. 31, 2023 USD ($)	Jul. 31, 2023 $ / shares shares
Class of Stock [Line Items]
Payments for repurchase of common stock | $		$ 106,131	$ 0
Common Class A [Member]
Class of Stock [Line Items]
Common stock, number of classes of stock | Class	1	1
Common stock, shares authorized (in shares) | shares	1,000,000	1,000,000			1,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.000025	$ 0.000025			$ 0.000025
Common stock, shares issued (in shares) | shares	246,932	246,932			239,607
Common stock, shares outstanding (in shares) | shares	246,932	246,932			239,607
Common stock number of votes per share | Vote	1	1
Stock repurchase program, authorized amount | $				$ 350,000
Repurchase and retirement of common stock (in shares) | shares	800	2,200
Stock repurchase price (in dollars per share) | $ / shares	$ 60.64	$ 48.46
Payments for repurchase of common stock | $	$ 46,900	$ 106,100
Stock repurchase program, remaining authorization amount | $	$ 243,900	$ 243,900

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands

1 Months Ended

9 Months Ended

Aug. 01, 2023 shares

Dec. 31, 2022 USD ($) PurchasePeriod shares

Aug. 01, 2022 shares

Dec. 13, 2019 USD ($) PurchasePeriod shares

Dec. 13, 2019 USD ($) PurchasePeriod shares

Jan. 31, 2024 $ / shares shares

Aug. 31, 2023 $ / shares shares

Aug. 31, 2022 $ / shares shares

Oct. 31, 2021 $ / shares shares

Dec. 31, 2020 $ / shares shares

Sep. 30, 2016 shares

Apr. 30, 2024 USD ($) Plan $ / shares shares

Apr. 30, 2023 USD ($)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares available for grant (in shares)

18,300,000

Grants in period (in shares)

0

Exercises in period (in shares)

600,000

Weighted average exercise price (in dollars per share) | $ / shares

$ 5.18

Options outstanding (in shares)

400,000

Options, weighted average exercise price | $ / shares

$ 9.47

Contractual term

8 months 12 days

Options outstanding, intrinsic value | $

$ 20,700

Monetary cap | $

$ 25,000

$ 25,000

$ 25,000

Share cap (in shares)

1,000

1,000

Offering period duration (in months)

12 months

12 months

Number of six-month purchase periods | PurchasePeriod

2

2

2

Proceeds from stock plans | $

50,660

$ 23,268

Compensation not yet recognized | $

$ 649,300

Period for recognition (in years)

2 years 4 months 24 days

Employee Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares reserved for future issuance (in shares)

44,200,000

RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

10,923,000

Granted (in dollars per share) | $ / shares

$ 35.44

2016 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of equity incentive plans | Plan

1

2016 Plan | Common Class A [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares reserved for future issuance (in shares)

22,400,000

Annual increase (in shares)

18,000,000

Annual increase, percent of outstanding shares

5%

Number of additional shares authorized

12,000,000

11,300,000

2010 Stock Plan and 2011 Stock Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of inactive equity incentive plans | Plan

2

Market Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Equity instruments outstanding (in shares)

2,600,000

Market Stock Units | RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

800,000

1,300,000

400,000

700,000

Granted (in dollars per share) | $ / shares

$ 47.09

$ 27.89

$ 46.2

$ 35.69

Vesting percentage

200%

200%

200%

133%

Award vesting period

2 years 10 months 24 days

2 years 10 months 24 days

2 years 9 months 18 days

4 years

Market Stock Units | President and Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

200,000

Granted (in dollars per share) | $ / shares

$ 62.85

Vesting percentage

200%

Award vesting period

3 years 7 months 6 days

Performance Restricted Stock Units | RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares)

300,000

Granted (in dollars per share) | $ / shares

$ 45.86

Vesting percentage

200%

Award vesting period

3 years 7 months 6 days

Employee Stock Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares reserved for future issuance (in shares)

10,700,000

Percent of eligible compensation (up to)

15%

15%

15%

Purchase price of common stock, percent

85%

85%

ESPP stock issued during period (in shares)

1,900,000

Proceeds from stock plans | $

$ 47,300

Employee Stock Purchase Plan | Common Class A [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares reserved for future issuance (in shares)

13,800,000

13,800,000

13,800,000

Equity Incentive Plans - RSU (D

Equity Incentive Plans - RSU (Details) - RSUs shares in Thousands	9 Months Ended
	Apr. 30, 2024 $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares) | shares	24,774
Granted (in shares) | shares	10,923
Released (in shares) | shares	(9,076)
Forfeited (in shares) | shares	(1,092)
Outstanding, ending balance (in shares) | shares	25,529
Grant Date Fair Value per Share
Beginning Outstanding (in dollars per share) | $ / shares	$ 24.46
Granted (in dollars per share) | $ / shares	35.44
Released (in dollars per share) | $ / shares	25.54
Forfeited (in dollars per share) | $ / shares	25.74
Ending Outstanding (in dollars per share) | $ / shares	$ 28.72

Equity Incentive Plans - ESPP (

Equity Incentive Plans - ESPP (Details) - Employee Stock Purchase Plan	9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	9 months 10 days	8 months 26 days
Risk-free interest rate	5.10%	4.20%
Volatility	47.20%	60.50%
Dividend yield	0%	0%

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 82,292	$ 72,908	$ 252,259	$ 239,153
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	18,901	19,383	61,110	63,425
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	38,719	32,003	117,664	107,116
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	16,705	13,126	47,594	42,426
Product | Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,576	1,831	5,201	6,103
Support, entitlements and other services | Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 6,391	$ 6,565	$ 20,690	$ 20,083

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 4,687	$ 5,161	$ 15,905	$ 14,774

Restructuring Charges (Addition

Restructuring Charges (Additional Information) (Details) $ in Millions	1 Months Ended	9 Months Ended		22 Months Ended
	Aug. 31, 2022 Employee	Apr. 30, 2024 USD ($)	Apr. 30, 2023 USD ($)	Apr. 30, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring description	In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represented approximately 4% of our total employees
Cash payments		$ 0.4	$ 15.8
Restructuring Charges		$ 0	$ 5.3
Sales and marketing expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				$ 13.4
Research And Development Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				2.3
Support entitlements and other services cost of revenue [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				0.4
General and administrative expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				0.2
Employee [Member]
Restructuring Cost and Reserve [Line Items]
Number of employees reduced our global headcount | Employee	270
Number of employees reduced our global headcount, Percent	4%
One-time severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				$ 16.3

Net Income (Loss) Per Share - C

Net Income (Loss) Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Apr. 30, 2024	Jan. 31, 2024	Oct. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Apr. 30, 2024	Apr. 30, 2023
Earnings Per Share [Abstract]
Net (loss) income	$ (15,616)	$ 32,795	$ (15,853)	$ (70,969)	$ (70,790)	$ (99,514)	$ 1,326	$ (241,273)
Add: Interest expense related to convertible senior notes, net of tax	0			0			12,749	0
Diluted net (loss) income	$ (15,616)			$ (70,969)			$ 14,075	$ (241,273)
Weighted average shares, basic	245,766			234,735			243,688	231,702
Add: Dilutive effect of common stock equivalents	0			0			53,367	0
Weighted average shares, diluted	245,766			234,735			297,055	231,702
Net (loss) income per share attributable to common stockholders, basic	$ (0.06)			$ (0.3)			$ 0.01	$ (1.04)
Net (loss) income per share attributable to common stockholders, diluted	$ (0.06)			$ (0.3)			$ 0.05	$ (1.04)

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares shares in Thousands	9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	473	67,134
Outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	473	28,116
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	2,032
Common stock issuable upon the conversion of the Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	36,986

Segment Information - Additiona

Segment Information - Additional information (Details)	9 Months Ended
	Apr. 30, 2024 Segment
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable segments	1

Segment Information - Schedule

Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 524,577	$ 448,581	$ 1,600,864	$ 1,368,685
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	283,842	233,835	882,790	764,972
Europe, the Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	147,065	124,248	423,566	346,065
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	82,502	77,742	258,763	226,047
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 11,168	$ 12,756	$ 35,745	$ 31,601

Segment Information - Schedul_2

Segment Information - Schedule of Sets Forth Long-Lived Assets Include Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jul. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 114,785	$ 111,865
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	81,266	78,404
Non-US [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 33,519	$ 33,461

SUBSEQUENT EVENT (Additional In

SUBSEQUENT EVENT (Additional Information) (Details) - 2026 Notes - USD ($) shares in Millions, $ in Millions	Jul. 31, 2024	Apr. 30, 2024
Subsequent Event [Line Items]
Aggregate principal amount		$ 817.6
Subsequent Event [Member]
Subsequent Event [Line Items]
Conversion, converted cash amount	$ 817.6
Subsequent Event [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Conversion converted, Shares delivered	16.9